RA Capital Management

Ra Capital Management as of June 30, 2025

Portfolio Holdings for Ra Capital Management

Ra Capital Management holds 63 positions in its portfolio as reported in the June 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Ascendis Pharma A/s - SH (ASND) 29.9 $1.8B 10M 172.60
Vaxcyte SH (PCVX) 6.6 $389M 12M 32.51
Rhythm Pharmaceuticals SH (RYTM) 5.9 $351M 5.6M 63.19
Janux Therapeutics SH (JANX) 4.4 $259M 11M 23.10
Avidity Biosciences SH (RNA) 3.5 $206M 7.3M 28.40
Arcellx SH (ACLX) 3.4 $200M 3.0M 65.85
89bio SH (ETNB) 3.3 $195M 20M 9.82
Ars Pharmaceuticals SH (SPRY) 3.2 $190M 11M 17.45
Newamsterdam Pharma Co Nv SH (NAMS) 3.1 $184M 10M 18.11
Sionna Therapeutics SH (SION) 3.1 $181M 10M 17.35
Cidara Therapeutics SH (CDTX) 2.8 $164M 3.4M 48.71
Edgewise Therapeutics SH (EWTX) 2.2 $130M 9.9M 13.11
Lenz Therapeutics SH (LENZ) 2.1 $123M 4.2M 29.31
Wave Life Sciences SH (WVE) 2.0 $118M 18M 6.50
Tyra Biosciences SH (TYRA) 2.0 $117M 12M 9.57
Gh Research SH (GHRS) 1.6 $94M 7.7M 12.19
Dyne Therapeutics SH (DYN) 1.6 $93M 9.7M 9.52
Geron Corp SH (GERN) 1.4 $85M 60M 1.41
Disc Medicine SH (IRON) 1.4 $84M 1.6M 52.96
Mineralys Therapeutics SH (MLYS) 1.4 $83M 6.1M 13.53
Septerna SH (SEPN) 1.2 $74M 7.0M 10.57
Fulcrum Therapeutics SH (FULC) 1.2 $70M 10M 6.88
Bicara Therapeutics SH (BCAX) 1.1 $65M 7.0M 9.29
Vor Biopharma SH (VOR) 1.1 $64M 40M 1.62
Taysha Gene Therapies SH (TSHA) 0.9 $54M 24M 2.31
Dianthus Therapeutics SH (DNTH) 0.9 $53M 2.9M 18.63
Rxsight SH (RXST) 0.8 $48M 3.7M 13.00
Tourmaline Bio SH (TRML) 0.7 $41M 2.5M 15.99
Scholar Rock Holding Corp SH (SRRK) 0.7 $40M 1.1M 35.42
Climb Bio SH (CLYM) 0.7 $39M 31M 1.24
Structure Therapeutics SH (GPCR) 0.5 $32M 1.5M 20.74
Solid Biosciences SH (SLDB) 0.5 $28M 5.8M 4.87
Metsera SH (MTSR) 0.3 $19M 676k 28.45
Monopar Therapeutics SH (MNPR) 0.3 $18M 511k 35.78
Nkarta SH (NKTX) 0.3 $18M 11M 1.66
Larimar Therapeutics SH (LRMR) 0.3 $18M 6.0M 2.89
Acumen Pharmaceuticals SH (ABOS) 0.3 $17M 15M 1.16
Enliven Therapeutics SH (ELVN) 0.3 $17M 849k 20.06
Travere Therapeutics SH (TVTX) 0.3 $17M 1.2M 14.80
4d Molecular Therapeutics In SH (FDMT) 0.3 $17M 4.6M 3.71
Hinge Health Inc-a SH (HNGE) 0.3 $16M 300k 51.75
Artiva Biotherapeutics SH (ARTV) 0.3 $15M 9.9M 1.51
Pepgen SH (PEPG) 0.2 $12M 11M 1.11
Jade Biosciences SH (JBIO) 0.2 $11M 1.1M 9.99
Tango Therapeutics SH (TNGX) 0.2 $10M 2.0M 5.12
Acrivon Therapeutics SH (ACRV) 0.2 $9.9M 8.3M 1.19
Eledon Pharmaceuticals SH (ELDN) 0.2 $9.7M 3.6M 2.71
Arcus Biosciences SH (RCUS) 0.2 $9.3M 1.1M 8.14
Perceptive Capital Solutions SH (PCSC) 0.1 $8.0M 750k 10.62
Omada Health SH (OMDA) 0.1 $7.3M 400k 18.30
Werewolf Therapeutics SH (HOWL) 0.1 $7.3M 6.7M 1.09
Beta Bionics SH (BBNX) 0.1 $7.3M 500k 14.56
Cytomx Therapeutics SH (CTMX) 0.1 $6.0M 2.7M 2.27
10x Genomics Inc-class A SH (TXG) 0.1 $5.5M 475k 11.58
Surrozen SH (SRZN) 0.1 $5.4M 603k 8.94
Genedx Holdings Corp SH (WGS) 0.1 $5.4M 58k 92.31
Avalo Therapeutics SH (AVTX) 0.1 $4.7M 933k 4.99
Adicet Bio SH (ACET) 0.1 $4.6M 7.5M 0.61
Mbx Biosciences SH (MBX) 0.1 $4.3M 378k 11.41
Protara Therapeutic SH (TARA) 0.1 $3.1M 1.0M 3.03
Newamsterdam Pharma Co Nv-27 SH (NAMSW) 0.0 $2.7M 333k 8.00
Acadia Healthcare SH (ACHC) 0.0 $2.0M 89k 22.69
Inflarx Nv SH (IFRX) 0.0 $1.6M 2.0M 0.79